Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting CVKD Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline HGV Q1 2026 Earnings Stellar EPS Beat Surpasses Expectations by 922 Crown Crafts Inc CRWS Q1 2026 Earnings Earnings Beat With EPS of 014 Despite Sparse Disclosures ADAML Q1 2026 Earnings Preferred Stock Delivers Strong EPS Surprise Stock Edges Higher